Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending February 27, 2012. The report details a specific share repurchase transaction executed in accordance with shareholder authority granted at the Annual General Meeting on May 5, 2011.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on capital structure and share buyback activity.
- Shares Purchased: 400,000 Ordinary shares of 25 pence each.
- Purchase Date: February 27, 2012.
- Price Range: Highest price paid was 1,405.5 pence per share; lowest price paid was 1,382.5 pence per share.
- Treasury Holdings (Settled): 506,382,927 shares (9.11% of total issued share capital).
- Treasury Holdings (Including Unsettled): 507,607,927 shares (10.05% of total voting rights).
- Shares in Issue (Excluding Treasury): 5,049,454,017 shares.
Material Changes
The primary material change reported is the reduction of outstanding shares through the purchase of 400,000 shares for Treasury. Consequently, the percentage of total voting rights held in Treasury increased to 10.05% when including unsettled purchases. The filing does not provide comparative financial data to assess changes in operational performance versus prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities and is made in conformity with the Financial Services Authority's Disclosure and Transparency Rules.
Key Facts for Investor Verification
- Verify the total cost of the 400,000 shares purchased based on the reported price range (1,382.5 to 1,405.5 pence).
- Confirm the impact of the 10.05% Treasury holding on the denominator for shareholder notification thresholds under Disclosure and Transparency Rules.
- Check subsequent filings for the settlement status of the shares included in the "unsettled" count.
- Note that this filing does not contain financial performance metrics (revenue, earnings, cash flow) for the period.